Trying times for painkiller choices. Vioxx, Bextra, and Celebrex can increase the risk for heart attack and other cardiovascular problems. So can the old standbys, like ibuprofen and acetaminophen.
出版信息
Harv Heart Lett. 2006 Oct;17(2):1-3.
PMID:17153752
Abstract
摘要
相似文献
1
2
COX-2 inhibitors--a lesson in unexpected problems.环氧化酶-2抑制剂——一个有关意外问题的教训。
N Engl J Med. 2005 Mar 17;352(11):1131-2. doi: 10.1056/NEJMe058038. Epub 2005 Feb 15.
3
Coxibs and cardiovascular disease.昔布类药物与心血管疾病
N Engl J Med. 2004 Oct 21;351(17):1709-11. doi: 10.1056/NEJMp048288. Epub 2004 Oct 6.
4
Cyclooxygenase-2 inhibitors and cardiovascular risk.环氧化酶-2抑制剂与心血管风险。
Can J Cardiol. 2005 Mar;21(3):307-8.
5
[COX-2 inhibitors--one step forward and two steps back].[环氧化酶-2抑制剂——前进一小步，后退两大步]
Tidsskr Nor Laegeforen. 2005 Apr 7;125(7):875-8.
6
[Vision impairment by COX-2 inhibitor and the sequelae of voluntary Vioxx recall].[环氧化酶-2抑制剂导致的视力损害及万络自愿召回的后遗症]
Klin Monbl Augenheilkd. 2005 Jan;222(1):62-3. doi: 10.1055/s-2004-813884.
7
Does the pro-hypertensive effect of cyclooxygenase-2 inhibitors account for the increased risk in cardiovascular disease?环氧化酶-2抑制剂的促高血压作用是否导致了心血管疾病风险的增加？
Am J Cardiol. 2005 Sep 15;96(6):872-3. doi: 10.1016/j.amjcard.2005.05.038.
8
Drug safety. FDA panel urges caution on many anti-inflammatory drugs.药物安全。美国食品药品监督管理局专家小组敦促对多种抗炎药保持谨慎。
Science. 2005 Feb 25;307(5713):1183-5. doi: 10.1126/science.307.5713.1183a.
9
The lessons of Vioxx.万络事件的教训。
N Engl J Med. 2005 Sep 29;353(13):1420-1; author reply 1420-1. doi: 10.1056/NEJMc055294.
10
Raising the safety bar--the FDA's coxib meeting.提高安全标准——美国食品药品监督管理局的环氧化酶-2抑制剂会议
N Engl J Med. 2005 Mar 31;352(13):1283-5. doi: 10.1056/NEJMp058055.
Zotero 插件